198 related articles for article (PubMed ID: 15156530)
1. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Tumlin JA; Hennigar RA
Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
[TBL] [Abstract][Full Text] [Related]
2. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
Tumlin JA; Lohavichan V; Hennigar R
Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
[TBL] [Abstract][Full Text] [Related]
4. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
5. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
[TBL] [Abstract][Full Text] [Related]
7. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
[TBL] [Abstract][Full Text] [Related]
8. Steroid and cyclophosphamide in IgA nephropathy.
Roccatello D; Ferro M; Cesano G; Rossi D; Berutti S; Salomone M; Piccoli G; Sena LM
Nephrol Dial Transplant; 2000 Jun; 15(6):833-5. PubMed ID: 10831636
[TBL] [Abstract][Full Text] [Related]
9. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of steroid pulse therapy in combination with mizoribine following tonsillectomy for immunoglobulin A nephropathy in renally impaired patients.
Kaneko T; Shimizu A; Tsuruoka S; Iino Y; Katayama Y
J Nippon Med Sch; 2013; 80(4):279-86. PubMed ID: 23995570
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcome of IgA nephropathy in children from one single center experience.
Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of crescentic IgA nephropathy after renal transplantation.
Zagkotsis G; Vourlakou C; Paraskevopoulos A; Apostolou T
CEN Case Rep; 2018 Nov; 7(2):268-273. PubMed ID: 29802527
[TBL] [Abstract][Full Text] [Related]
14. Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.
Ramachandran R; Doddi P; Nandakrishna B; Nada R; Kumar V; Rathi M; Kohli HS; Jha V; Sakhuja V; Gupta KL
Int Urol Nephrol; 2015 Nov; 47(11):1917-8. PubMed ID: 26411427
[No Abstract] [Full Text] [Related]
15. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall.
D'Amico G; Napodano P; Ferrario F; Rastaldi MP; Arrigo G
Kidney Int; 2001 Feb; 59(2):682-92. PubMed ID: 11168950
[TBL] [Abstract][Full Text] [Related]
16. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
Ballardie FW; Roberts ISD
J Am Soc Nephrol; 2002 Jan; 13(1):142-148. PubMed ID: 11752031
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
18. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes.
Chen KJ; Cheng CH; Wu MJ; Chen CH; Shu KH
J Chin Med Assoc; 2003 May; 66(5):263-70. PubMed ID: 12908567
[TBL] [Abstract][Full Text] [Related]
19. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
20. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
García Camín RM; Cabezas A; Calero F; Ballarín JA
Nefrologia; 2004; 24 Suppl 3():68-71. PubMed ID: 15219073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
